The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg.

Tauber PA, Kratzer B, Schatzlmaier P, Smole U, Köhler C, Rausch L, Kranich J, Trapin D, Neunkirchner A, Zabel M, Jutz S, Steinberger P, Gadermaier G, Brocker T, Stockinger H, Derdak S, Pickl WF

Open source

DOI
10.3389/fimmu.2023.1094694
Published
2023
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1094694,
  title = {The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg.},
  author = {Tauber PA and Kratzer B and Schatzlmaier P and Smole U and Köhler C and Rausch L and Kranich J and Trapin D and Neunkirchner A and Zabel M and Jutz S and Steinberger P and Gadermaier G and Brocker T and Stockinger H and Derdak S and Pickl WF},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1094694},
  url = {https://doi.org/10.3389/fimmu.2023.1094694}
}

RIS

TY  - JOUR
TI  - The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg.
AU  - Tauber PA
AU  - Kratzer B
AU  - Schatzlmaier P
AU  - Smole U
AU  - Köhler C
AU  - Rausch L
AU  - Kranich J
AU  - Trapin D
AU  - Neunkirchner A
AU  - Zabel M
AU  - Jutz S
AU  - Steinberger P
AU  - Gadermaier G
AU  - Brocker T
AU  - Stockinger H
AU  - Derdak S
AU  - Pickl WF
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1094694
UR  - https://doi.org/10.3389/fimmu.2023.1094694
ER  - 

APA

PA, T., B, K., P, S., U, S., C, K., L, R., J, K., D, T., A, N., M, Z., S, J., P, S., G, G., T, B., H, S., S, D., & WF, P. (2023). The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1094694

Source records